B. Bielecka, I. Gorczyca-Głowacka, Agnieszka Ciba-Stemplewska, B. Wożakowska-Kapłon
{"title":"非瓣膜性心房颤动患者血栓栓塞并发症的二级预防——与指南相关的临床实践","authors":"B. Bielecka, I. Gorczyca-Głowacka, Agnieszka Ciba-Stemplewska, B. Wożakowska-Kapłon","doi":"10.5114/ms.2023.129051","DOIUrl":null,"url":null,"abstract":"Introduction: Atrial fibrillation (AF) patients after past thromboembolic complications are at high risk of such subsequent complications and should undergo anticoagulant therapy. Aim of the research: To assess recommended anticoagulant prophylaxis in AF patients after past thromboembolic complications, and an attempt to identify predictors","PeriodicalId":81014,"journal":{"name":"Contributions in medical studies","volume":"94 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Secondary prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation – clinical practice in relation to guidelines\",\"authors\":\"B. Bielecka, I. Gorczyca-Głowacka, Agnieszka Ciba-Stemplewska, B. Wożakowska-Kapłon\",\"doi\":\"10.5114/ms.2023.129051\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Atrial fibrillation (AF) patients after past thromboembolic complications are at high risk of such subsequent complications and should undergo anticoagulant therapy. Aim of the research: To assess recommended anticoagulant prophylaxis in AF patients after past thromboembolic complications, and an attempt to identify predictors\",\"PeriodicalId\":81014,\"journal\":{\"name\":\"Contributions in medical studies\",\"volume\":\"94 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contributions in medical studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ms.2023.129051\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contributions in medical studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ms.2023.129051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Secondary prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation – clinical practice in relation to guidelines
Introduction: Atrial fibrillation (AF) patients after past thromboembolic complications are at high risk of such subsequent complications and should undergo anticoagulant therapy. Aim of the research: To assess recommended anticoagulant prophylaxis in AF patients after past thromboembolic complications, and an attempt to identify predictors